EP
CVS icon

Edgestream Partners’s CVS Health CVS Stock Holding History

Edgestream Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23M Buy
11,862
+2,720
+30% +$243K 0.04% 628
2026
Q1 		$657K Buy
+9,142
New +$704K 0.02% 697
2025
Q3 		– Sell
-6,268
Closed -$432K – 910
2025
Q2 		$432K Buy
+6,268
New +$411K 0.01% 749
2024
Q4 		– Sell
-20,734
Closed -$1.3M – 892
2024
Q3 		$1.3M Buy
20,734
+1,437
+7% +$83.8K 0.06% 515
2024
Q2 		$1.14M Buy
+19,297
New +$1.21M 0.05% 489
2024
Q1 		– Sell
-10,287
Closed -$812K – 847
2023
Q4 		$812K Buy
10,287
+2,682
+35% +$191K 0.06% 488
2023
Q3 		$531K Buy
7,605
+4,169
+121% +$295K 0.04% 584
2023
Q2 		$238K Sell
3,436
-81,600
-96% -$5.81M 0.02% 664
2023
Q1 		$6.32M Buy
85,036
+57,994
+214% +$4.86M 0.7% 16
2022
Q4 		$2.52M Buy
27,042
+22,807
+539% +$2.2M 0.28% 106
2022
Q3 		$404K Sell
4,235
-15,895
-79% -$1.57M 0.03% 367
2022
Q2 		$1.86M Buy
20,130
+5,806
+41% +$567K 0.15% 213
2022
Q1 		$1.45M Buy
+14,324
New +$1.5M 0.12% 267
2019
Q2 		– Sell
-150,551
Closed -$8.12M – 239
2019
Q1 		$8.12M Buy
+150,551
New +$9.29M 1.19% 22
2016
Q2 		– Sell
-12,716
Closed -$1.32M – 50
2016
Q1 		$1.32M Buy
12,716
+7,793
+158% +$758K 1.48% 17
2015
Q4 		$481K Sell
4,923
-8,273
-63% -$810K 1.37% 26
2015
Q3 		$1.27M Sell
13,196
-17,926
-58% -$1.88M 2.23% 11
2015
Q2 		$3.26M Buy
31,122
+21,387
+220% +$2.19M 2.25% 9
2015
Q1 		$1M Buy
9,735
+2,167
+29% +$219K 1.31% 26
2014
Q4 		$729K Sell
7,568
-4,388
-37% -$387K 1.66% 17
2014
Q3 		$952K Sell
11,956
-3,666
-23% -$289K 0.83% 34
2014
Q2 		$1.18M Buy
+15,622
New +$1.18M 0.75% 36

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Edgestream Partners's CVS Position: Q2 2026 in Review

Edgestream Partners increased its CVS Health (CVS) stake by 30% in Q2 2026, buying an estimated $243K and bringing the position to 11,862 shares worth $1.23M. The position accounts for 0.04% of the portfolio, ranked #628.

Edgestream Partners first reported a position in CVS in Q2 2014 and has held it in 22 quarters since. The position peaked at $8.12M in Q1 2019. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Edgestream Partners held 11,862 shares of CVS Health worth $1.23M as of Q2 2026.
  • Edgestream Partners bought 2,720 CVS Health shares in Q2 2026, an estimated $243K.
  • CVS Health made up 0.04% of Edgestream Partners's portfolio in Q2 2026, its #628 holding.
  • Edgestream Partners first reported a position in CVS Health in Q2 2014 and has held it in 22 quarters since.
  • Edgestream Partners's CVS Health position peaked at $8.12M in Q1 2019.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Edgestream Partners's 13F filing for Q2 2026, filed 11 Aug 2026.